Clinical decision support and palivizumab: A means to protect from respiratory syncytial virus

Applied Clinical Informatics

Volumn 6, Issue 4, 2015, Pages 769-784

  Utidjian, L H ^a,b   Hogan, A ^a   Michel, J ^b   Localio, A R ^a   Karavite, D ^b   Song, L ^b   Ramos, M J ^b   Fiks, A G ^a,b   Lorch, S ^a   Grundmeier, R W ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Clinical decision support; Electronic health records; Palivizumab; Respiratory syncytial virus

Indexed keywords

PALIVIZUMAB;

CLINICAL DECISION SUPPORT SYSTEM; FEMALE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; MALE; NEWBORN; PATIENT SELECTION; PHYSIOLOGY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEASON; WORKFLOW;

DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PALIVIZUMAB; PATIENT SELECTION; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SEASONS; WORKFLOW;

EID: 84953290435     PISSN: None     EISSN: 18690327     Source Type: Journal    
DOI: 10.4338/ACI-2015-08-RA-0096     Document Type: Article

References (30)

1. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282(15): 1440-1446.
2. Boyce TG, Mellen BG, Mitchel EF Jr, et al. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. The Journal of Pediatrics 2000;137(6): 865-870.
3. American Academy of Pediatrics. Respiratory Syncytial Virus. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL; 2012. pp. 609-618.
4. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360(6): 588-598.
5. The IMpact-RSV Study Group. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. Pediatrics 1998; 102(3): 531-537.
6. Parnes C, Guillermin J, Habersang R, et al. Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry. Pediatr Pulmonol 2003; 35(6): 484-489.
7. Committee on Infectious Diseases. Policy Statement-Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 2009; 124(6): 1694-1701.
8. Andabaka T, Nickerson JW, Rojas-Reyes MX, et al. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev 2013; 4: CD006602.
9. Anderson LJ, Dormitzer PR, Nokes DJ, et al. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine 2013; 31 (Suppl. 2): B209-B215.
10. Hampp C. Cost-effectiveness of Respiratory Syncytial Virus Prophylaxis in Various Indications. Arch Pediatr Adolesc Med 2011; 165(6): 498.
11. Committee on Infectious Diseases and Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014; 134(2): 415-420.
12. Frogel MP, Stewart DL, Hoopes M, et al. A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis. J Manag Care Pharm 2010; 16(1): 46-58.
13. Anderson KS, Mullally VM, Fredrick LM, et al. Compliance with RSV prophylaxis: Global physicians' perspectives. Patient Prefer Adherence 2009; 3: 195-203.
14. Frogel M, Nerwen C, Cohen A, et al. Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry J Perinatol 2008; 28(7): 511-517.
15. Afghani B, Ngo T, Leu S-Y, et al. The effect of an interventional program on adherence to the American Academy of Pediatrics guidelines for palivizumab prophylaxis. Pediatr Infect Dis J 2006; 25(11): 1019-1024.
16. Berner ES. Clinical decision support systems: state of the art. AHRQ Publication No. 09-0069-EF. Rockville, MD: Agency for Healthcare Research and Quality 2009: 1-26.
17. Fiks AG, Grundmeier RW, Biggs LM, et al. Impact of Clinical Alerts Within an Electronic Health Record on Routine Childhood Immunization in an Urban Pediatric Population. Pediatrics 2007; 120(4): 707-714.
18. Fiks AG, Hunter KF, Localio AR, et al. Impact of Electronic Health Record-Based Alerts on Influenza Vaccination for Children With Asthma. Pediatrics 2009; 124(1): 159-169.
19. Fiks AG, Grundmeier RW, Mayne S, et al. Effectiveness of Decision Support for Families, Clinicians, or Both on HPV Vaccine Receipt. Pediatrics 2013; 131(6): 1114-1124.
20. Lundeen K, Pfeiffenberger T, Jacobson Vann J, et al. Evaluation of a novel web-based prior approval application for palivizumab prophylaxis of respiratory syncytial virus in a state Medicaid program. J Manag Care Pharm 2013; 19(2): 115-124.
21. Shiffman RN, Karras BT, Agrawal A, et al. GEM: A Proposal for a More Comprehensive Guideline Document Model Using XML. Journal of the American Medical Informatics Association 2000; 7(5): 488-498.
22. Karavite D, Fiks AG, Grundmeier RW. Developing Guideline Based Clinical Decision Support for Premature Infant Care. medicine.yale.edu. [cited 2014 Aug 20]. Available from: http://medicine.yale.edu/cmi/ glides/localize/555_148593_CHOPImpGuide4.5.13.pdf
23. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics 2009; 42(2): 377-381.
24. Bracht M, Basevitz D, Cranis M, et al. Identifying and ensuring optimal care for all children at risk of developing serious respiratory syncytial virus disease: a Canadian nurses' perspective. Neonatal Netw 2012; 31(6): 369-386.
25. Shojania KG, Jennings A, Mayhew A, et al. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev 2009; (3): CD001096.
26. Goldstein MK, Hoffman BB, Coleman RW, et al. Patient safety in guideline-based decision support for hypertension management: ATHENA DSS. Journal of the American Medical Informatics Association 2002; 9: S11-S16.
27. van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. Journal of the American Medical Informatics Association 2006; 13(2): 138-147.
28. Synagis (palivizumab) for intramuscular injection. Gaithersburg, MD: Medimmune; 2014 Mar. Package Insert.
29. Centers for Medicare & Medicaid Services. EHR Incentive Programs: Stage 2. [cited 2014 Nov 10]. Available from: http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/ Stage_2.html
30. Center for Disease Control & Prevention. National Vital Statistics System-Birth Data. cdc.gov. [cited 2015 Feb 20]. Available from: http://www.cdc.gov/nchs/births.htm